Seres Therapeutics Inc (MCRB)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.02B
EV to revenue ratio (TTM)
45.09
EV to ebitda
0.98
Financial Performance
Revenue (TTM)
$0.00B
Gross profit (TTM)
-$0.05B
EBITDA
-$0.07B
Profitability
Operating margin (TTM)
-2,101.00%
Profit margin
<0.01%
Return on assets (TTM)
-39.90%
Return on equity (TTM)
-66.60%
Per Share Metrics
Revenue per share (TTM)
$0.20
EPS
-$5.01
Diluted EPS (TTM)
-$5.01
Book value
$4.63
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
10.82
PEG ratio
-0.11
Price to sales ratio (TTM)
8.45
Price to book ratio (TTM)
0.81
Growth
Quarterly earnings growth (YoY)
-93.40%
Quarterly revenue growth (YoY)
-91.90%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.56